[HTML][HTML] Nanotechnology in pulmonary medicine

M Doroudian, A O'Neill, R Mac Loughlin… - Current opinion in …, 2021 - Elsevier
Nanotechnology in medicine—nanomedicine—is extensively employed to diagnose, treat,
and prevent pulmonary diseases. Over the last few years, this brave new world has made …

Recent applications and strategies in nanotechnology for lung diseases

W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …

Nanomedicines targeting respiratory injuries for pulmonary disease management

D Liu, M Long, L Gao, Y Chen, F Li… - Advanced Functional …, 2022 - Wiley Online Library
The respiratory system holds crucial importance in the biology of vertebrate animals. Injuries
of the respiratory system caused by viral infections (eg, by COVID‐19, MERS, and SARS) …

[HTML][HTML] Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design

Q Qiao, X Liu, T Yang, K Cui, L Kong, C Yang… - … Pharmaceutica Sinica B, 2021 - Elsevier
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation
and destruction of the lung air–blood barrier, leading to irreversible and substantial …

Nanomedicine for respiratory diseases

U Pison, T Welte, M Giersig, DA Groneberg - European journal of …, 2006 - Elsevier
Nanotechnology provides new materials in the nanometer range with many potential
applications in clinical medicine and research. Due to their unique size-dependent …

Nanotechnology based therapeutics for lung disease

M Doroudian, R MacLoughlin, F Poynton… - Thorax, 2019 - thorax.bmj.com
Nanomedicine is a multidisciplinary research field with an integration of traditional sciences
such as chemistry, physics, biology and materials science. The application of nanomedicine …

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

SR Bonam, NG Kotla, RA Bohara, Y Rochev… - Nano today, 2021 - Elsevier
Abstract COVID-19, coronavirus disease 2019, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this …

Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives

M Chen, Z Shou, X Jin, Y Chen - Drug Delivery, 2022 - Taylor & Francis
A boom in respiratory tract infection cases has inflicted a socio-economic burden on the
healthcare system worldwide, especially in developing countries. Limited alternative …

Nanomedicine-based therapeutics to combat acute lung injury

S Bian, H Cai, Y Cui, W Liu, C Xiao - International Journal of …, 2021 - Taylor & Francis
Acute lung injury (ALI) or its aggravated stage acute respiratory distress syndrome (ARDS)
may lead to a life-threatening form of respiratory failure, resulting in high mortality of up to 30 …

Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: critical appraisal of newer …

X Gao, L Guo, J Li, HE Thu, Z Hussain - Journal of Controlled Release, 2018 - Elsevier
Lung cancer (LC) is the second most prevalent type of cancer and primary cause of mortality
among both men and women, worldwide. The most commonly employed diagnostic …